EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the Biological Relationship between Migraine and Depression

Adrián Viudez-Martínez, Abraham B Torregrosa, Francisco Navarrete iD, María Salud García-Gutiérrez iD

Biomolecules · 2024

DOI: 10.3390/biom14020163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Adrián Viudez-Martínez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy Service, Hospital General Dr. Balmis de Alicante, 03010 Alicante, Spain. Hauptthemen laut MEDLINE: Depression, Migraine Disorders. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 463 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine is a highly prevalent neurological disorder. Among the risk factors identified, psychiatric comorbidities, such as depression, seem to play an important role in its onset and clinical course. Patients with migraine are 2.5 times more likely to develop a depressive disorder; this risk becomes even higher in patients suffering from chronic migraine or migraine with aura. This relationship is bidirectional, since depression also predicts an earlier/worse onset of migraine, increasing the risk of migraine chronicity and, consequently, requiring a higher healthcare expenditure compared to migraine alone. All these data suggest that migraine and depression may share overlapping biological mechanisms. Herein, this review explores this topic in further detail: firstly, by introducing the common epidemiological and risk factors for this comorbidity; secondly, by focusing on providing the cumulative evidence of common biological aspects, with a particular emphasis on the serotoninergic system, neuropeptides such as calcitonin-gene-related peptide (CGRP), pituitary adenylate cyclase-activating polypeptide (PACAP), substance P, neuropeptide Y and orexins, sexual hormones, and the immune system; lastly, by remarking on the future challenges required to elucidate the etiopathological mechanisms of migraine and depression and providing updated information regarding new key targets for the pharmacological treatment of these clinical entities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionMigraine DisordersHumansPituitary Adenylate Cyclase-Activating PolypeptideCalcitonin Gene-Related PeptideNeuropeptide Y

Stichwörter der Autor:innen

immune systemmajor depressive disordermigraineneuropeptidesserotoninsexual hormones

Substanzen

Pituitary Adenylate Cyclase-Activating PolypeptideCalcitonin Gene-Related PeptideNeuropeptide Y

Autor:innen und Institutionen

  • Hospital Pharmacy Service, Hospital General Dr. Balmis de Alicante, 03010 Alicante, Spain.
  • Instituto de Neurociencias, Universidad Miguel Hernández, 03550 San Juan de Alicante, Spain.
  • Research Network on Primary Addictions, Instituto de Salud Carlos III, MICINN and FEDER, 28029 Madrid, Spain.
  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), 03010 Alicante, Spain.

ORCID-Profile: Francisco Navarrete, María Salud García-Gutiérrez

Zitieren

APA

Viudez-Martínez, A., Torregrosa, A. B., Navarrete, F., & García-Gutiérrez, M. S. (2024). Understanding the Biological Relationship between Migraine and Depression. Biomolecules. https://doi.org/10.3390/biom14020163

Vancouver

Viudez-Martínez A, Torregrosa AB, Navarrete F, García-Gutiérrez MS. Understanding the Biological Relationship between Migraine and Depression. Biomolecules. 2024. doi:10.3390/biom14020163

BibTeX
@article{ViudezMartnez2024,
  author = {Viudez-Martínez, Adrián and Torregrosa, Abraham B and Navarrete, Francisco and García-Gutiérrez, María Salud},
  title = {Understanding the Biological Relationship between Migraine and Depression},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14020163}
}
Kostenlos starten →